Literature DB >> 8654162

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

M G Ghany1, C Leissinger, R Lagier, R Sanchez-Pescador, A S Lok.   

Abstract

Chronic liver disease due to hepatitis C virus (HCV) infection is a major problem in hemophiliacs. Recent reports suggested that hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus (HIV) have an increased incidence of liver failure but the mechanism of accelerated liver injury is not clear. We tested plasma from 100 hemophiliacs for anti-HCV by second generation ELISA, anti-HIV by EIA, and HCV RNA and HIV RNA by branched DNA and polymerase chain reaction assays to determine if hemophiliacs coinfected with HCV and HIV have higher HCV RNA levels and more active liver disease. Seventy-nine (79%) patients were anti-HCV positive, of whom 85% were HCV RNA positive. None of the anti-HCV-negative patients had detectable HCV RNA in plasma. Forty-two (42%) patients were anti-HIV positive, of whom 47% had detectable HIV RNA. All the anti-HIV-positive patients were also anti-HCV positive. The prevalence of both anti-HCV and anti-HIV increased significantly with age. There was no difference in HCV RNA levels between anti-HIV-positive and anti-HIV-negative patients (mean: 21 +/- 4 vs 18 +/- 5 Meq/ml), although HCV RNA levels were significantly higher in anti-HIV-positive patients with CD4 counts < 200/mm3 (P = 0.008). There was an inverse correlation between HCV RNA levels and CD4 counts but no correlation was found between HCV RNA and serum aminotransferase levels. We found a high prevalence of HCV and HIV coinfection in our hemophiliacs. Hepatitis C virus replication appears to be increased in patients with severe immunodeficiency secondary to progressive HIV infection. However, there was no correlation between HCV RNA and serum ALT level, suggesting that HCV is not directly cytopathic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654162     DOI: 10.1007/bf02088247

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

Review 1.  The safety of blood components and derivatives.

Authors:  C Julius; R G Westphal
Journal:  Hematol Oncol Clin North Am       Date:  1992-10       Impact factor: 3.722

2.  Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.

Authors:  A S Lok; D Chien; Q L Choo; T M Chan; E K Chiu; I K Cheng; M Houghton; G Kuo
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

3.  Correlation of Australia antigen with posttransfusion hepatitis.

Authors:  D J Gocke; H B Greenberg; N B Kavey
Journal:  JAMA       Date:  1970-05-04       Impact factor: 56.272

4.  Safety of therapeutic products used for hemophilia patients.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-07-29       Impact factor: 17.586

Review 5.  Current risk of transfusion-associated human immunodeficiency virus infection.

Authors:  J E Menitove
Journal:  Arch Pathol Lab Med       Date:  1990-03       Impact factor: 5.534

6.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

7.  The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion".

Authors:  M V Ragni; O K Ndimbie; E O Rice; F A Bontempo; S Nedjar
Journal:  Blood       Date:  1993-08-01       Impact factor: 22.113

8.  The progression of HCV-associated liver disease in a cohort of haemophilic patients.

Authors:  P Telfer; C Sabin; H Devereux; F Scott; G Dusheiko; C Lee
Journal:  Br J Haematol       Date:  1994-07       Impact factor: 6.998

9.  Hepatitis C viremia in patients with hepatitis C virus infection.

Authors:  A S Lok; R Cheung; R Chan; V Liu
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

10.  Abnormal serum transaminase levels in patients with hemophilia A.

Authors:  A I Cederbaum; P M Blatt; P H Levine
Journal:  Arch Intern Med       Date:  1982-03
View more
  9 in total

Review 1.  Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

Authors:  K E Nelson; D L Thomas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

3.  Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.

Authors:  J M Matthews-Greer; G C Caldito; S D Adley; R Willis; A C Mire; R M Jamison; K L McRae; J W King; W L Chang
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

5.  Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.

Authors:  Solveig Tenckhoff; Thorsten Kaiser; Fritz Bredeek; Sharyne Donfield; Erika Menius; Alice Lail; Joachim Mössner; Eric S Daar; Hans L Tillmann
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

Review 6.  Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.

Authors:  Kara W Chew; Debika Bhattacharya
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 7.  Natural History of Hepatitis C.

Authors:  Shilpa Lingala; Marc G Ghany
Journal:  Gastroenterol Clin North Am       Date:  2015-08-25       Impact factor: 3.806

8.  TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.

Authors:  Stacey A Rizza; Kishore B Challagundla; Sekar Natesampillai; Gary D Bren; Jaromir Sykora; Henning Walczak; Andrew D Badley
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

9.  Serum viral markers in Iranian patients with congenital bleeding disorder.

Authors:  Mohsen Nassirtoosi; Manije Lak; Katayoun Karimi; Mohammadreza Managchi; Katayoun Samimi-Rad; Alireza Abdollahi; Reza Shahsiah
Journal:  Ann Saudi Med       Date:  2008 Nov-Dec       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.